Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) reported revenue of ₹44.63 Cr and net profit of ₹1.02 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
The statements below are read from Aarey Drugs & Pharmaceuticals Limited’s filed results, 30 filed quarters and 11 fiscal years on record, standalone basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 15, 2026 · audited
| ₹ Cr | Jun2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026Latest | YoYlatest |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 67.4 | 78.4 | 137 | 66.2 | 63.6 | 59.6 | 111 | 25.2 | 49.0 | 95.1 | 97.5 | 135 | 140 | 120 | 117 | 76.3 | 62.5 | 158 | 51.0 | 57.8 | 76.5 | 210 | 127 | 105 | 108 | 102 | 84.2 | 96.4 | 189 | 44.6 | -56.3% |
| 66.5 | 77.6 | 136 | 65.6 | 63.2 | 59.1 | 112 | 24.4 | 50.5 | 95.5 | 95.5 | 132 | 138 | 119 | 118 | 72.0 | 60.9 | 160 | 49.6 | 56.0 | 73.8 | 212 | 126 | 101 | 113 | 101 | 81.5 | 97.9 | 185 | 43.3 | -56.9% | |
| Operating profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -0.60 | 4.27 | 1.53 | -2.18 | 1.34 | 1.85 | 2.70 | -1.44 | 1.18 | 3.72 | -4.85 | 1.70 | 2.64 | -1.51 | 4.34 | 1.33 | -22.2% |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -0.5% | 5.6% | 2.4% | -1.4% | 2.6% | 3.2% | 3.5% | -0.7% | 0.9% | 3.5% | -4.5% | 1.7% | 3.1% | -1.6% | 2.3% | 3.0% | +1.3 pp |
| Other income | 1.25 | 0.73 | 1.82 | 1.51 | 0.92 | 0.85 | 3.42 | 0.74 | 2.55 | 2.09 | 0.67 | 0.81 | 0.13 | 1.13 | 2.35 | -0.94 | 0.48 | 5.54 | 0.70 | 0.84 | 0.29 | 5.14 | 1.58 | 0.02 | 7.54 | 1.55 | 0.79 | 4.18 | -0.43 | 1.72 | +10.5% |
| Interest | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.55 | 0.59 | 0.71 | 1.02 | 0.89 | 1.27 | 1.06 | 1.15 | 0.96 | 1.51 | 2.48 | 1.04 | 1.26 | 0.92 | 1.78 | 1.67 | +61.4% |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.41 | 0.42 | 0.55 | 0.20 | 0.42 | 0.41 | 0.47 | 0.40 | 0.47 | 0.49 | -1.42 | 0.49 | 0.69 | 0.83 | 0.85 | 0.85 | +74.1% |
| Profit before tax | 2.10 | 1.55 | 3.18 | 2.10 | 1.30 | 1.40 | — | 1.56 | 1.85 | 1.70 | 2.73 | 3.12 | 2.20 | 1.98 | 0.80 | 2.32 | 0.75 | 2.64 | 0.72 | 1.01 | 1.47 | 2.15 | 1.33 | 1.75 | 1.63 | 1.73 | 1.48 | 0.92 | 1.28 | 0.52 | -70.2% |
| Tax % | — | — | 76.9% | — | — | — | — | 12.8% | — | — | 8.1% | 9.0% | 11.4% | 88.5% | 0.0% | -8.8% | 33.7% | 48.7% | 0.0% | 22.1% | 30.2% | -0.3% | 6.9% | 8.6% | 71.1% | 20.6% | 30.9% | -38.3% | -21.7% | -98.5% | -119.2 pp |
| Net profit | 2.10 | 1.55 | 0.74 | 2.10 | 1.30 | 1.40 | 1.00 | 1.36 | 1.85 | 1.70 | 2.51 | 2.84 | 1.95 | 0.23 | 0.80 | 2.53 | 0.49 | 1.35 | 0.72 | 0.78 | 1.02 | 2.15 | 1.24 | 1.60 | 0.47 | 1.37 | 1.02 | 1.28 | 1.56 | 1.02 | -25.4% |
| EPS (₹) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.32 | 0.83 | 0.19 | 0.14 | 0.29 | 0.31 | 0.40 | 0.77 | 0.88 | 1.14 | 0.04 | 0.48 | 0.36 | 0.20 | 0.55 | 0.36 | -25.0% |
